Insider · CIK 0001836662

Tang Carolyn C.

Reports to the SEC for 1 company · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001836662

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	RCUSArcus Biosciences, Inc.M Exercise/Conversion	General Counsel	MExercise/Conversion	+34.1K sh	$2.57	+$87.7K	184,607
2026-06-11	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	General Counsel	MExercise/Conversion	−34.1K sh	$2.57	−$87.7K	0
2026-01-23	RCUSArcus Biosciences, Inc.A Award	General Counsel	AAward	+24K sh	—	—	148,734
2026-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	General Counsel	AAward	+96K sh	—	—	96,000
2025-12-17	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−6,810 sh	$22.16	−$151K	124,734
2025-12-16	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−7,658 sh	$21.88	−$168K	131,544
2025-01-23	RCUSArcus Biosciences, Inc.A Award	General Counsel	AAward	+37K sh	—	—	137,623
2025-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	General Counsel	AAward	+150K sh	—	—	150,000
2024-12-15	RCUSArcus Biosciences, Inc.F Tax Payment	General Counsel	FTax Payment	−11.3K sh	$16.08	−$182K	100,623
2024-06-15	RCUSArcus Biosciences, Inc.F Tax Payment	General Counsel	FTax Payment	−4,182 sh	$16.97	−$71K	111,364
2024-01-23	RCUSArcus Biosciences, Inc.A Award	General Counsel	AAward	+26.7K sh	—	—	114,579
2024-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	General Counsel	AAward	+108K sh	—	—	108,200
2023-12-19	RCUSArcus Biosciences, Inc.D Disposition to Issuer	General Counsel	DDisposition to Issuer	−4,076 sh	$18.09	−$73.7K	87,879
2023-12-18	RCUSArcus Biosciences, Inc.D Disposition to Issuer	General Counsel	DDisposition to Issuer	−3,991 sh	$17.74	−$70.8K	91,955
2023-06-16	RCUSArcus Biosciences, Inc.D Disposition to Issuer	General Counsel	DDisposition to Issuer	−2,892 sh	$19.35	−$56K	95,902
2023-01-23	RCUSArcus Biosciences, Inc.A Award	General Counsel	AAward	+34K sh	—	—	97,539
2023-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	General Counsel	AAward	+138K sh	—	—	138,200
2022-12-16	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−2,125 sh	$30.66	−$65.2K	28,982
2022-12-16	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−398 sh	$31.23	−$12.4K	28,584
2022-06-17	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−449 sh	$21.71	−$9,747.79	24,982
2022-06-17	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−1,073 sh	$22.29	−$23.9K	23,909
2022-06-16	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−1,400 sh	$20.72	−$29K	25,431
2022-03-08	RCUSArcus Biosciences, Inc.A Award	General Counsel	AAward	+16.3K sh	—	—	33,814
2022-03-08	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	General Counsel	AAward	+65K sh	—	—	65,000
2021-12-17	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−138 sh	$38.79	−$5,352.703	18,048
2021-12-17	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−88 sh	$39.67	−$3,491.127	17,960
2021-12-17	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−171 sh	$40.57	−$6,938.017	17,789
2021-12-17	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−225 sh	$41.42	−$9,320.355	17,564
2021-12-16	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−356 sh	$39.59	−$14.1K	18,317
2021-12-16	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−131 sh	$40.46	−$5,299.802	18,186
2021-06-17	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−1,606 sh	$23.68	−$38K	15,362
2021-06-16	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−1,257 sh	$24.13	−$30.3K	17,020
2021-06-16	RCUSArcus Biosciences, Inc.S Sale	General Counsel	SSale	−52 sh	$24.77	−$1,288.04	16,968
2021-01-19	RCUSArcus Biosciences, Inc.A Award	General Counsel	AAward	+12.5K sh	—	—	19,886
2021-01-19	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	General Counsel	AAward	+75.2K sh	—	—	75,225

Recent filings

Accepted (ET)
Jun 124
Tang Carolyn C.0001836662-26-000005
SEC(opens sec.gov)
Jan 264
Tang Carolyn C.0001836662-26-000002
SEC(opens sec.gov)
Dec 184
Tang Carolyn C.0001836662-25-000005
SEC(opens sec.gov)
Jan 274
Tang Carolyn C.0001724521-25-000021
SEC(opens sec.gov)
Dec 174
Tang Carolyn C.0001724521-24-000183
SEC(opens sec.gov)
Jun 184
Tang Carolyn C.0001724521-24-000126
SEC(opens sec.gov)
Jan 254
Tang Carolyn C.0001724521-24-000027
SEC(opens sec.gov)
Dec 204
Tang Carolyn C.0001724521-23-000070
SEC(opens sec.gov)
Jun 164
Tang Carolyn C.0001209191-23-038160
SEC(opens sec.gov)
Jan 254
Tang Carolyn C.0001209191-23-004874
SEC(opens sec.gov)
Dec 164
Tang Carolyn C.0001209191-22-061761
SEC(opens sec.gov)
Jun 214
Tang Carolyn C.0001209191-22-038399
SEC(opens sec.gov)

Companies

Arcus Biosciences, Inc.General CounselRCUS

Address

C/O ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY

HAYWARD, CA, 94545